0.629
Finanzdaten der Barinthus Biotherapeutics Plc Adr-Aktie (BRNS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
1,100%
0.156
|
0.013 | 0.329 | - | 14.97 |
|
|
34.77%
15.22
|
23.34 | 20.93 | 23.57 | 24.56 |
| Benefits Costs and Expenses |
30.08%
14.80
|
21.16 | 20.01 | 20.59 | 23.10 |
| Costs And Expenses |
34.77%
15.22
|
23.34 | 20.93 | 20.59 | 23.10 |
| Other Operating Income/Expenses |
1,100%
0.156
|
0.013 | 0.329 | 0.184 | 0.21 |
| Operating Income/Loss |
35.41%
-15.07
|
-23.32 | -20.60 | -23.39 | -9.38 |
| Nonoperating Income/Loss |
80.49%
0.424
|
2.173 | 0.92 | 2.802 | 1.248 |
| Income/Loss From Continuing Operations Before Tax |
30.77%
-14.64
|
-21.15 | -19.68 | -20.59 | -8.132 |
| Income Tax Expense/Benefit, Deferred |
184.00%
-0.071
|
-0.025 | -0.022 | 0.003 | -0.003 |
| Income Tax Expense/Benefit |
184.00%
-0.071
|
-0.025 | -0.022 | 0.003 | -0.003 |
| Income/Loss From Continuing Operations After Tax |
31.03%
-14.57
|
-21.13 | -19.66 | -20.59 | -8.129 |
|
|
31.03%
-14.57
|
-21.13 | -19.66 | -20.59 | -8.129 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
150.00%
-0.005
|
-0.002 | -0.01 | -0.051 | -0.015 |
| Basic Average Shares |
0.79%
40.66
|
40.34 | 40.27 | 0.269 | 39.42 |
| Diluted Average Shares |
0.79%
40.66
|
40.34 | 40.27 | 0.269 | 39.42 |
| Basic Earnings Per Share |
30.77%
-0.36
|
-0.52 | -0.49 | -0.51 | -0.21 |
| Diluted Earnings Per Share |
30.77%
-0.36
|
-0.52 | -0.49 | -0.51 | -0.21 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):